Dr Daniel Maspoch is a chemist who has always maintained a rewarding balance between fundamental and applied research, with pioneering developments in the field of porous reticular materials and delivery systems. He is the author of over 203 articles and 6 book chapters. In 2021 and 2022, he got the prestigious ERC Advanced Grant and a second ERC Proof-of-Concept Grant, respectively. In addition, he was awarded an ERC Consolidator Grant in 2014, and his first ERC Proof-of-Concept Grant in 2019. Recently, in 2023 he has received the prestigious Rei Jaume I award 2023 in New Technologies. In 2022, he was appointed new Corresponding Academician of the Physical and Chemical Sciences Section, in the specialty of Materials Science by the Royal Spanish Academy of Science (RAC). In 2020, he was rewarded with the Research Excellence Award from the Spanish Royal Society of Chemistry, and in 2015 he was awarded the Premio Marcial Moreno Mañas Lectureship. From the technology transfer side, several technologies and materials developed by his group have been transferred –through licensing patents or signing technology transfer contracts– to various companies. The high technological and socioeconomical impact of his research is supported by: the co-development of three technologies based on delivery systems that are available on the market (LuctaCaps®, Fungipol@CP and a product of LipoferTM family); the signature of 4 technology transfer contracts; the filling of 13 patents, from which 4 have been licensed; the co- founding of the spin-off company Ahead Therapeutics; and the collaboration with 19 private companies (e.g. KAO Co.., LG Display, CEPSA, LACER, etc.) through bilateral projects/contracts. Dr Maspoch graduated in Chemistry at the Universitat de Girona and obtained his PhD in Materials Science at the Universitat Autònoma de Barcelona & Institut de Ciència de Materials de Barcelona working in the group of Prof. Jaume Veciana and Prof. Concepció Rovira. He then moved to Northwestern University, where he worked as a postdoctoral fellow in the group of professor Chad A. Mirkin. Since September 2011 he is ICREA Research Professor and Group Leader at the Institut Català de Nanociència i Nanotecnologia (ICN2).
.png)
